Captor Therapeutics S.A.
CTX | WSX
Overview
Corporate Details
- ISIN(s):
- PLCPTRT00014 (+1 more)
- LEI:
- 259400JHH1S2I2S4O735
- Country:
- Poland
- Address:
- Wrocław Duńska 11, 54-427 Wrocław
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Captor Therapeutics is a biopharmaceutical company focused on development of protein degradation drugs for cancer and autoimmune diseases, which have limited or no known treatment options. Targeted Protein Degradation (TPD) combats the therapeutic limits of small molecules with overcoming drug resistance and uncoupling their pharmacokinetics from pharmacodynamics. Breakthrough TPD technology allows degradation of virtually any intracellular protein including the so-called "undruggable proteome". Captor Therapeutics is a Swiss-Polish company. Captor GmbH entity operates in Basel, the pharma hub of Switzerland, providing excellent opportunities for business development, while our state-of-the-art laboratories are located in Wroclaw, Poland. Our integrated competencies and expertise in biology and chemistry allow us to perform all stages of early drug development.
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-30 19:45 |
Declaration of Voting Results & Voting Rights Announcements
załącznik nr 9 - informacja o ogólnej liczbie głosów
|
Polish | 129.2 KB | |
| 2025-05-30 19:45 |
Declaration of Voting Results & Voting Rights Announcements
załącznik nr 8 - wzór instrukcji wykonywania prawa głosu przez pełnomocnika
|
Polish | 270.2 KB | |
| 2025-05-30 19:45 |
Proxy Solicitation & Information Statements
załącznik nr 7 - wzór pełnomocnictwa
|
Polish | 87.3 KB | |
| 2025-05-30 19:45 |
Corporate Governance Report
załącznik nr 6 - sprawozdanie Rady Nadzorczej Spółki za rok 2024
|
Polish | 829.9 KB | |
| 2025-05-30 19:45 |
Remuneration Report
załącznik nr 5 - raport niezależnego biegłego rewidenta z wykonania usługi dają…
|
Polish | 404.7 KB | |
| 2025-05-30 19:45 |
Remuneration Report
załącznik nr 4 - sprawozdanie o wynagrodzeniach za rok 2024
|
Polish | 795.6 KB | |
| 2025-05-30 19:45 |
Declaration of Voting Results & Voting Rights Announcements
załącznik nr 3 - treść uchwały Rady Nadzorczej pozytywnie opiniującej projekty …
|
Polish | 65.9 KB | |
| 2025-05-30 19:45 |
AGM Report
załącznik nr 2 - projekty uchwał ZWZ
|
Polish | 268.5 KB | |
| 2025-05-30 19:45 |
General Meeting Notice
załącznik nr 1 - ogłoszenie
|
Polish | 141.7 KB | |
| 2025-05-30 19:45 |
General Meeting Notice
Ogłoszenie o zwołaniu Zwyczajnego Walnego Zgromadzenia oraz dokumenty związane …
|
Polish | 1.6 KB | |
| 2025-05-30 18:33 |
Board/Management Change
załącznik nr 3
|
Polish | 100.8 KB | |
| 2025-05-30 18:33 |
Board/Management Change
załącznik nr 2
|
Polish | 115.7 KB | |
| 2025-05-30 18:33 |
Board/Management Change
załącznik nr 1
|
Polish | 16.9 KB | |
| 2025-05-30 18:33 |
Board/Management Change
Zmiany w składzie Zarządu Spółki - Powołanie Zarządu na nową kadencję - Content…
|
Polish | 3.1 KB | |
| 2025-05-29 17:03 |
Directors' Dealings
załącznik
|
Polish | 4.4 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |